Citigroup
CAI

Citigroup’s Caris Life Sciences CAI Stock Holding History

Citigroup’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98M Buy
111,236
+34,056
+44% +$610K ﹤0.01% 2943
2026
Q1 		$1.38M Buy
77,180
+46,455
+151% +$1.02M ﹤0.01% 2904
2025
Q4 		$829K Sell
30,725
-17,720
-37% -$499K ﹤0.01% 3251
2025
Q3 		$1.47M Buy
48,445
+48,433
+403,608% +$1.54M ﹤0.01% 2915
2025
Q2 		$321 Buy
+12
New +$323 ﹤0.01% 5461

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Citigroup's CAI Position: Q2 2026 in Review

Citigroup increased its Caris Life Sciences (CAI) stake by 44% in Q2 2026, buying an estimated $610K and bringing the position to 111,236 shares worth $1.98M. The position accounts for ﹤0.01% of the portfolio, ranked #2943.

Citigroup first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Citigroup held 111,236 shares of Caris Life Sciences worth $1.98M as of Q2 2026.
  • Citigroup bought 34,056 Caris Life Sciences shares in Q2 2026, an estimated $610K.
  • Caris Life Sciences made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2943 holding.
  • Citigroup first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.